Cargando…
Different Susceptibilities of Human Melanoma Cell Lines to G2/M Blockage and Cell Death Activation in Response to the Estrogen Receptor β agonist LY500307
Background: Gender differences in melanoma incidence, metastasis formation and disease progression are increasingly evident in epidemiological studies, with women showing significantly better survival than men. Among factors possibly underlying the disparities, sex hormones seem to play a key role....
Autores principales: | Pontecorvi, Giada, Bellenghi, Maria, Tait, Sabrina, Tirelli, Valentina, Matarrese, Paola, Mattia, Gianfranco, Carè, Alessandra, Puglisi, Rossella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965114/ https://www.ncbi.nlm.nih.gov/pubmed/35371312 http://dx.doi.org/10.7150/jca.65425 |
Ejemplares similares
-
Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma
por: Sareddy, Gangadhara R., et al.
Publicado: (2016) -
Biomarkers for Diagnosis, Prognosis and Response to Immunotherapy in Melanoma
por: Puglisi, Rossella, et al.
Publicado: (2021) -
Sex and Gender Disparities in Melanoma
por: Bellenghi, Maria, et al.
Publicado: (2020) -
SCD5 restored expression favors differentiation and epithelial-mesenchymal reversion in advanced melanoma
por: Puglisi, Rossella, et al.
Publicado: (2018) -
Non-genomic Effects of Estrogen on Cell Homeostasis and Remodeling With Special Focus on Cardiac Ischemia/Reperfusion Injury
por: Puglisi, Rossella, et al.
Publicado: (2019)